Abstract
Regorafenib (Stivarga(A (R))) is an oral small-molecule multiple kinase inhibitor. It is indicated worldwide for patients with metastatic colorectal c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
